el Esper N, Gregoire I, Fievet P, Westeel P F, Gondry J, Lalau J D, Fournier A
Service de néphrologie, CHU Amiens.
Arch Mal Coeur Vaiss. 1990 Jul;83(8):1099-102.
Plasma volume and the pressor dose of angiotensin II were estimated in 15 normotensive pregnant women during the second and third trimester and 2-3 months post-partum together. Plasma volume estimated by the Evans Blue technique increased during pregnancy significantly more than the body weight: its increase was 37 and 54% of the post-partum values whereas the body weight increase was only 6 and 12%. The pressor dose of angiotensin II was significantly increased during pregnancy only when it was related to body weight (14.2 +/- 4.3 and 14.9 +/- 5.2 at the 2nd and 3rd trimester versus 11.2 +/- 2.9 ng min-1 kg-1 BW post-partum) but not when it was related to plasma volume (0.25 +/- 07 and 0.26 +/- 0.09 versus 0.25 +/- 0.07 ng min-1 ml-1 PV). It is concluded that the increased pressor dose of angiotensin II (related to body weight) observed in normal pregnancy cannot be interpreted as an evidence for decreased vascular reactivity but that it could be a mere reflection of plasma volume increase.
对15名血压正常的孕妇在妊娠中期和晚期以及产后2至3个月期间的血浆容量和血管紧张素II的升压剂量进行了估算。通过伊文思蓝技术估算的血浆容量在孕期的增加幅度显著高于体重:其增加量分别为产后值的37%和54%,而体重增加仅为6%和12%。血管紧张素II的升压剂量仅在与体重相关时在孕期显著增加(妊娠中期和晚期分别为14.2±4.3和14.9±5.2,而产后为11.2±2.9 ng·min⁻¹·kg⁻¹体重),但与血浆容量相关时则无显著变化(分别为0.25±0.07和0.26±0.09,产后为0.25±0.07 ng·min⁻¹·ml⁻¹血浆容量)。结论是,正常妊娠中观察到的血管紧张素II升压剂量增加(与体重相关)不能被解释为血管反应性降低的证据,而可能仅仅是血浆容量增加的反映。